Last 2 days to apply for this exciting postdoc position investigating early lung fibrosis at @kingscollegelondon.bsky.social - please do consider!

New postdoc position in my lab investigating interstitial lung abnormalities (ILA) and mechanisms driving early lung fibrosis @kingscollegelondon.bsky.social @rbandh.bsky.social @gstt-nhs.bsky.social @crick.ac.uk

Closing date 7th August.

Please do consider applying!

my.corehr.com/pls/coreport...

Our Review just published in Thorax takes a fresh look at how ageing-associated cellular changes lead to epithelial dysfunction and vulnerability, priming the development of pulmonary fibrosis. @jennydickens41.bsky.social @lpearmain.bsky.social

thorax.bmj.com/content/earl...

Interested in lung epithelial ageing in IPF? Check out our new review - just landed in Thorax @drrjhewitt.bsky.social @lpearmain.bsky.social thorax.bmj.com/content/thor...

In the FIBRONEER-IPF phase 3 trial, nerandomilast slowed disease progression in patients with idiopathic pulmonary fibrosis as compared with placebo. Full trial results: nej.md/4mgWcIU

#ATS2025 @atscommunity.bsky.social

New postdoc position investigating interstitial lung abnormalities (ILA) and mechanisms driving early lung fibrosis @kingscollegelondon.bsky.social @rbandh.bsky.social @gstt-nhs.bsky.social @crick.ac.uk

Please do consider applying:
www.jobs.ac.uk/job/DLS668/p...

Closing date 18th Feb.

New postdoc position investigating interstitial lung abnormalities (ILA) and mechanisms driving early lung fibrosis @kingscollegelondon.bsky.social @rbandh.bsky.social @gstt-nhs.bsky.social @crick.ac.uk

Please do consider applying:
www.jobs.ac.uk/job/DLS668/p...

Closing date 18th Feb.

We’re conducting a quick, anonymous survey to better understand current practices for managing interstitial lung abnormalities (ILAs) in the UK. Your insights can help improve care pathways and outcomes.

⏱️ Takes just 5 minutes to complete!

👉 tinyurl.com/ytsupxwk

Thanks